Less Ads, More Data, More Tools Register for FREE

Director dealings: Derwent London CEO sells just ahead of Brexit vote

Thu, 23rd Jun 2016 15:19

(ShareCast News) - Derwent London chief executive John Burns has sold £1.5m of the FTSE 250 real estate investor's shares in the week just before the EU referendum which could seriously lift or undermine the company's shares.In Wednesday's sale, which comes two days before results for Britain's referendum on continuing EU membership that has hit the shares of most property stocks in recent months, Burns sold 45,000 shares at a price of £33.075 apiece.A fortnight ago, fellow director Simon Silver, who is in charge of the company's development and regeneration programme, sold 30,000 of his shares at £33.29 per share.First-quarter results just over a month ago were strong, with Derwent reporting strong letting activity and development progress, including securing £13.2m of annual rental income by letting or pre-letting 185,400 square feet.Derwent said lettings were 6.1% ahead of December 2015 estimated recovery value on average and confirmed it had a one million square feet development programme under construction.If the UK votes to stay in the EU, some observers predict shares of London-focused property companies such as Derwent could soar.Top Director BuysVinaland Ltd (VNL)Director name: Isaac ,CharlesAmount purchased: 170,000 @ $0.58Value: $98,600.00Workspace Group (WKP)Director name: Hopkins,JamieAmount purchased: 8,054 @ 839.96pValue: £67,650.29Globalworth Real Estate Investments Limited (GWI)Director name: Raptis,Dimitris Amount purchased: 9,550 @ € 5.10Value: € 48,705.00Harworth Group (HWG)Director name: Kirkman ,Andrew Amount purchased: 50,000 @ 92.15pValue: £46,075.00Workspace Group (WKP)Director name: Clemett,GrahamAmount purchased: 4,922 @ 839.96pValue: £41,342.78Urban&civic (UANC)Director name: Butler,Robin Amount purchased: 16,546 @ 245.00pValue: £40,537.70Paysafe Group (PAYS)Director name: Dark,AndrewAmount purchased: 10,363 @ 385.85pValue: £39,985.64Totally (TLY)Director name: Holt,Robert (Bob)Amount purchased: 26,758 @ 63.60pValue: £17,018.09Harworth Group (HWG)Director name: Michaelson,OwenAmount purchased: 15,000 @ 91.90pValue: £13,785.00Immunodiagnostic Systems Holdings (IDH)Director name: Martin,Paul JamesAmount purchased: 10,000 @ 132.00pValue: £13,200.00Vianet Group (VNET)Director name: Dickson,JamesAmount purchased: 10,000 @ 100.00pValue: £10,000.00Stadium Group (SDM)Director name: Estell,JoanneAmount purchased: 12,000 @ 80.00pValue: £9,600.00Stadium Group (SDM)Director name: Peppiatt,CharlesAmount purchased: 10,000 @ 80.00pValue: £8,000.00Stadium Group (SDM)Director name: Brayshaw,Nick PAmount purchased: 10,000 @ 79.00pValue: £7,900.00Informa (INF)Director name: Owers,Helen Amount purchased: 1,000 @ 668.32pValue: £6,683.20Mitchells & Butlers (MAB)Director name: Jones,Timothy (Tim) CharlesAmount purchased: 1,162 @ 281.90pValue: £3,275.68Aberdeen Asian Income Fund Ltd. (AAIF)Director name: Arthur,PeterAmount purchased: 303 @ 165.00pValue: £499.95Fdm Group (holdings) (FDM)Director name: Senecal de Fonseca ,MichelleAmount purchased: 58 @ 590.60pValue: £342.55Kaz Minerals (KAZ)Director name: Southam,AndrewAmount purchased: 107 @ 140.80pValue: £150.66Fidessa Group (FDSA)Director name: Hamer,JohnAmount purchased: 6 @ 2,173.00pValue: £130.38Fidessa Group (FDSA)Director name: Skelton ,Andy Amount purchased: 5 @ 2,173.00pValue: £108.65Top Director SellsDerwent London (DLN)Director name: Burns,John DavidAmount purchased: 45,000 @ 3,307.50pValue: £1,488,375.03Consort Medical (CSRT)Director name: Glenn,JonathanAmount purchased: 96,820 @ 991.75pValue: £960,212.31Consort Medical (CSRT)Director name: Cotton,RichardAmount purchased: 55,153 @ 991.75pValue: £546,979.85

Related Shares

More News
17 Feb 2020 17:30

Recipharm Holds 91% Consort Stake, To Implement Compulsory Acquisition

Recipharm Holds 91% Consort Stake, To Implement Compulsory Acquisition

10 Feb 2020 12:52

Monday broker round-up

(Sharecast News) - Consort Medical: RBC Capital Markets upgrades to sector performer with a target price of 1,010p.

4 Feb 2020 18:03

Recipharm Lowers Acceptance Condition; Consort Offer Now Unconditional

Recipharm Lowers Acceptance Condition; Consort Offer Now Unconditional

29 Jan 2020 11:43

Recipharm To Make No Further Changes To Consort Medical Offer

Recipharm To Make No Further Changes To Consort Medical Offer

24 Jan 2020 09:57

Recipharm Extends Consort Medical Offer Deadline To February 4

Recipharm Extends Consort Medical Offer Deadline To February 4

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.